Literature DB >> 8583605

Prostaglandin E1 versus mixture of prostaglandin E1, papaverine and phentolamine in nonresponders to high papaverine plus phentolamine doses.

A Bechara1, A Casabé, G Chéliz, S Romano, N Fredotovich.   

Abstract

PURPOSE: We evaluated the efficacy of 40 micrograms/ml, prostaglandin E1 versus a combination of 17.64 mg./ml. papaverine hydrochloride, 0.58 mg./ml. phentolamine mesylate and 5.8 micrograms/ml. prostaglandin E1 (3-drug mixture).
MATERIALS AND METHODS: A total of 32 patients randomly received 1 ml. of either medication by the intracavernous route. All patients had presented with erectile dysfunction longer than 6 months in duration and had failed to respond to high doses of papaverine (60 mg.) plus phentolamine (1 mg).
RESULTS: Of 32 patients 7 (22%) responded to prostaglandin E1 and 16 (50%) to the 3-drug mixture, achieving erections allowing penetration (grade E4 or E5, p < 0.05). Pain was reported by 41% of the patients receiving prostaglandin E1 and 12.5% administered the 3-drug mixture.
CONCLUSIONS: The 3-drug mixture may be regarded as more effective than prostaglandin E1 alone in inducing an erectile response with a decreased incidence of pain.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8583605

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  7 in total

1.  Extending the rationale of combination therapy to unresponsive erectile dysfunction.

Authors:  Christopher Reece; Rajeev Kumar; Diedre Nienow; Ajay Nehra
Journal:  Rev Urol       Date:  2007

2.  Penile rehabilitation following treatment for prostate cancer: an analysis of the current state of the art.

Authors:  Tariq Al Shaiji; Trustin Domes; Gerald Brock
Journal:  Can Urol Assoc J       Date:  2009-02       Impact factor: 1.862

Review 3.  Erectile dysfunction.

Authors:  Mohit Khera; Irwin Goldstein
Journal:  BMJ Clin Evid       Date:  2011-06-29

4.  Health-related quality of life in men with erectile dysfunction.

Authors:  M S Litwin; R J Nied; N Dhanani
Journal:  J Gen Intern Med       Date:  1998-03       Impact factor: 5.128

5.  Evaluation of the sensitivity of different doses of vasoactive drugs in diagnosing erectile dysfunction in impotent patients: a prospective case-control study.

Authors:  Shady Zaki Said; Taha Abdel Nasser; Mohammad Ayad; Ahmad Tarek Motawi
Journal:  Cent European J Urol       Date:  2021-02-06

Review 6.  Intracavernosal therapy: when oral agents fail.

Authors:  A Nehra
Journal:  Curr Urol Rep       Date:  2001-12       Impact factor: 2.862

Review 7.  A summary of the controversy surrounding off-label medications in men's health.

Authors:  Adam Parker; Matthew Bruha; Oluwaseun Akinola; Charles Welliver
Journal:  Transl Androl Urol       Date:  2016-04
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.